Delivers yet another hit and run post, usual content! SP here reached a 52-week high yesterday WITHOUT a sales update Paolo, followed quickly by FDA approval in Argentina after the market closed. RNS 7am on Monday, don't be late Paolo!
Sounds like a weak response from a guy who is not even invested and is in denial. You chose to exit at 40p on or around 31st Jan. Just as it spiked around 17th/18th Feb you returned to this bb and went into deramping overdrive and this has continued to this date. You decided to wait in the hope that it would retrace to 40p, but it has kept on moving away from you. You are obviously struggling to let go!
Normal metrics cannot be applied to this company at this present time because of the uniqueness of the situation and the opportunity created.
The SP is doing the really important talking, don't you agree?
9iN (20:24) - No cash raise by the company so far! NCYT has the Golden Goose. The assay that sits at the top of the table, the very table that you questioned the existence of. Those so-called big pharmas must be going green with envy, I'm sure you can relate to that! Incidentally, have you forgotton that one of those pharma behemoths - Roche - endorsed NCYT'S diagnostic test last month!
Lorenzo06 - The fact that diagnostic tests have not even been evaluated and we're now in the middle of the pandemic, with the death toll rising daily, tells you all you need to know. Governments and Public Health Authorities have let us down badly. The WHO put the whole world on notice about this weeks ago. It warned that the window of preparedness was closing and that nations needed to act quickly. Yet just 3 days ago, our CMO, Chris Whitty, disclosed that some tests had not even been evaluated!
9iN (20:07) For the same reason GGP will not attract Institutional Investors, Havieron notwithstanding; too small & AIM listed. Surely you must know that! However, I'm sure the company will now be on the radar of all of the big pharmas if indeed it wasn't already. Do not forget that NCYT has completed an impressive hat-trick of diagnostic tests for SARS, Ebola and Covid-19. Might we accomplish a Covid-19 double of antigen and antibody tests! Do you think the NCYT scientists may have been working on an antibody test, or have they left that one alone 9iN?
9iN (19:42) The FACT is that the SP closed at a 52-week high yesterday without a sales update. Positive news flow will be with us for some time to come, certainly up to the annual results in less than 4 weeks. I'm still expecting a left field development too! All imo
RE: JUST NOW - PRIMER DESIGN tweeting about28 Mar 2020 19:56
Trintyman - thanks for your endorsement. It's incredible to think that the company submitted its EUA application to the US FDA in early February, and here we are now, almost two months on in the middle of the pandemic, with the CMO Chris Whitty pointing out that diagnostic tests have not even been evaluated. Look at the accreditations the NCYT test has managed to achieve in the interim. Worst of all, we're an anglo-french company. The right test has been here in the UK since January! The government has missed a trick with this one. All IMO
They still keep coming and their message is always the same; there's another all singing dancing test that they want to tell us about! But there's only one test at the top of the assay table! To all the O.P.P.S, the SP closed at a 52-week high yesterday without a sales update. RNS on Monday at 7am re latest FDA approval in Argentina, more positive news to follow.
RE: JUST NOW - PRIMER DESIGN tweeting about28 Mar 2020 17:08
Trintyman - the assay is the Golden Goose. I've been highlighting this for several weeks. It is the driver of sales, future business and obtaining FDA approvals. It is even more important now that Chris Whitty has correctly placed the emphasis on the need for accurate and reliable tests and now we have seen the dire consequences of using less than reliable tests in Spain. The NCYT marketing manager knew exactly what he was doing when he described the NCYT test as an 'unmatched [diagnostic] tool'.
We sell as many as we make, it's as simple as that!
Btw, every EUA application submitted by PrimerD to the FDAS throughout world will be successful.
It now feels like we have completed a dangerous circle. On 4th Feb, the US FDA issued EUA to the CDC'S diagnostic test. We all know the outcome. But at least these tests were not mass produced and did not enter the public domain, although the US was left without a reliable test for the whole of February for which they are now paying the price. However, now at the most critical time of the pandemic, particularly in Spain, unreliable tests , and many thousands of them, have found their way into the public domain almost two months after the failure of the CDC'S test. Serious failures with serious consequences.